Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis

Ticker
SXTC

Price
2.51
Stock movement up
+1.50 (0.70%)
Company name
China SXT Pharmaceuticals Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
165.92M
Ent value
154.04M
Price/Sales
86.04
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return (CAGR)
266.20%
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Last updated: 2025-12-04

iO Charts is a Seeking Alpha partner

DIVIDENDS

SXTC does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales86.04
Price to Book-
EV to Sales79.88

FINANCIALS

Per share

Loading...
Per share data
Current share count773.52K
EPS (TTM)-0.02
FCF per share (TTM)-0.01

Income statement

Loading...
Income statement data
Revenue (TTM)911.42K
Gross profit (TTM)232.67K
Operating income (TTM)-2.04M
Net income (TTM)-2.50M
EPS (TTM)-0.02
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)25.53%
Operating margin (TTM)-224.07%
Profit margin (TTM)-274.42%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash21.17M
Net receivables2.87M
Total current assets26.04M
Goodwill0.00
Intangible assets8.53K
Property, plant and equipment3.00M
Total assets26.35M
Accounts payable530.66K
Short/Current long term debt1.20M
Total current liabilities5.96M
Total liabilities6.12M
Shareholder's equity20.23M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-988.15K
Capital expenditures (TTM)2.02K
Free cash flow (TTM)-990.18K
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-12.36%
Return on Assets-9.49%
Return on Invested Capital-11.71%
Cash Return on Invested Capital-4.64%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open210.01
Daily high214.50
Daily low210.01
Daily Volume0K
All-time high14340000.00
1y analyst estimate-
Beta1.68
EPS (TTM)-0.02
Dividend per share0.00
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
SXTCS&P500
Current price drop from All-time high-100.00%-1.82%
Highest price drop-100.00%-56.47%
Date of highest drop20 Dec 20249 Mar 2009
Avg drop from high-100.00%-10.84%
Avg time to new high-12 days
Max time to new high290 days1805 days
COMPANY DETAILS
SXTC (China SXT Pharmaceuticals Inc) company logo
Marketcap
165.92M
Marketcap category
Small-cap
Description
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.
Employees
75
Investor relations
-
SEC filings
CEO
Feng Zhou
Country
USA
City
Taizhou
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...